Consultor le portail de référence du conseil en stratégie Consultor le portail de référence du conseil en stratégie

News, elucidation and outlooks
on strategy consulting

NASDAQ-listed pharmaceutical giant, ArrayBioPharma Inc. has announced it has appointed Shalini Sharp, (formerly chief financial officer and executive vice president of Ultragenyx Pharmaceutical) to the company's board of directors. For the last four years, Sharp has been responsible for leading Ultragenyx’s corporate finance, strategy, and information technology functions. But while she has now worked in life sciences for 20 years, Sharp was originally a successful management consultant at McKinsey and prior to that was an investment banker at Goldman Sachs. At McKinsey she worked at a business analyst for two years during 1995-1997. Her new role, on the audit committee of the board, will see her involved in the commercialisation of new drugs. She has an MBA from Harvard University (2001).

shalini sharp

Peter Crush for

See :

Consultor uses Cookies, to offer you the best service possible. If you continue using the website, you agree with our use of cookies.